Camber Pharmaceuticals Inc
Ron Cerminaro, RPh has a diverse work experience spanning from 1993 to the present. Ron has held various roles in different companies, showcasing their expertise in pharmaceuticals and biotech industry. Some of their notable positions include Vice President, Commercial Strategy and Operations at Camber Pharmaceuticals Inc, Director, Commercial Strategy and Operations at Camber Pharmaceuticals Inc, and Principal/President at Pharmaceutical Insights, LLC. Ron Cerminaro has also held roles such as Coordinator, Comparator Acquisitions at GlobalRx, Inc., Executive Director, Business Development USA at Celtis Healthcare, LLC, and Generic Rx Sourcing - Institutional & Team Lead Generic Operations at H. D. Smith. Ron has extensive experience in trade channel marketing, customer sales performance support, and pharmacy management.
Ron Cerminaro, RPh received their Bachelor of Science degree in Pharmacy from Rutgers University. Ron also completed a Mini-MBA in Global BioPharma Entrepreneurship from Rutgers University. In addition, they hold the certification of Registered Pharmacist and Licensed Immunizer from the New Jersey and New York Boards of Pharmacy, obtained in 2021.
This person is not in any offices
Camber Pharmaceuticals Inc
Camber is made up of three groups with one common goal: to be the best generics company in the industry. Camber Pharmaceuticals is rapidly growing and had an industry-leading 28 product approvals in 2022. With the support of our parent company, Hetero, we are poised to have a record number of product approvals and launches in 2023. Hetero, a world leader in API production and vertical manufacturing, is the foundation upon which Camber has maintained a 99% service level for our customers for the past two years. Hetero is investing over $250 million in the next three years in Camber products. The research and development team consists of over 1,000 scientists working to expand the types of drugs Camber offers, including novel delivery systems and complex molecules.